Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

345 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of a mathematical model of diabetes progression against observations in the Diabetes Prevention Program.
Hardy T, Abu-Raddad E, Porksen N, De Gaetano A. Hardy T, et al. Am J Physiol Endocrinol Metab. 2012 Jul 15;303(2):E200-12. doi: 10.1152/ajpendo.00421.2011. Epub 2012 May 1. Am J Physiol Endocrinol Metab. 2012. PMID: 22550065
Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.
Feldman PD, Hay LK, Deberdt W, Kennedy JS, Hutchins DS, Hay DP, Hardy TA, Hoffmann VP, Hornbuckle K, Breier A. Feldman PD, et al. J Am Med Dir Assoc. 2004 Jan-Feb;5(1):38-46. J Am Med Dir Assoc. 2004. PMID: 14706127
Retrospective analysis of diabetes risk in elderly patients with dementia in olanzapine clinical trials.
Micca JL, Hoffmann VP, Lipkovich I, Ahl J, Baker RW, Hardy TA. Micca JL, et al. Am J Geriatr Psychiatry. 2006 Jan;14(1):62-70. doi: 10.1097/01.JGP.0000192477.05061.96. Am J Geriatr Psychiatry. 2006. PMID: 16407583
Cross-sectional comparison of fasting lipids in normoglycemic patients with schizophrenia during chronic treatment with olanzapine, risperidone, or typical antipsychotics.
Hardy TA, Marquez E, Kryzhanovskaya L, Taylor CC, Cavazzoni P. Hardy TA, et al. J Clin Psychopharmacol. 2006 Aug;26(4):405-8. doi: 10.1097/01.jcp.0000227705.56870.06. J Clin Psychopharmacol. 2006. PMID: 16855460
Does treatment with duloxetine for neuropathic pain impact glycemic control?
Hardy T, Sachson R, Shen S, Armbruster M, Boulton AJ. Hardy T, et al. Diabetes Care. 2007 Jan;30(1):21-6. doi: 10.2337/dc06-0947. Diabetes Care. 2007. PMID: 17192327
Mathematical models of diabetes progression.
De Gaetano A, Hardy T, Beck B, Abu-Raddad E, Palumbo P, Bue-Valleskey J, Pørksen N. De Gaetano A, et al. Among authors: hardy t. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1462-79. doi: 10.1152/ajpendo.90444.2008. Epub 2008 Sep 9. Am J Physiol Endocrinol Metab. 2008. PMID: 18780774
Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder.
Lipkovich I, Jacobson JG, Hardy TA, Hoffmann VP. Lipkovich I, et al. BMC Psychiatry. 2008 Sep 15;8:78. doi: 10.1186/1471-244X-8-78. BMC Psychiatry. 2008. PMID: 18793440 Free PMC article.
A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes.
Barrington P, Chien JY, Showalter HD, Schneck K, Cui S, Tibaldi F, Ellis B, Hardy TA. Barrington P, et al. Among authors: hardy ta. Diabetes Obes Metab. 2011 May;13(5):426-33. doi: 10.1111/j.1463-1326.2011.01364.x. Epub 2011 Jan 19. Diabetes Obes Metab. 2011. PMID: 21251178 Clinical Trial.
Mathematical modeling of renal tubular glucose absorption after glucose load.
De Gaetano A, Panunzi S, Eliopoulos D, Hardy T, Mingrone G. De Gaetano A, et al. Among authors: hardy t. PLoS One. 2014 Jan 29;9(1):e86963. doi: 10.1371/journal.pone.0086963. eCollection 2014. PLoS One. 2014. PMID: 24489817 Free PMC article.
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.
Kazda CM, Ding Y, Kelly RP, Garhyan P, Shi C, Lim CN, Fu H, Watson DE, Lewin AJ, Landschulz WH, Deeg MA, Moller DE, Hardy TA. Kazda CM, et al. Diabetes Care. 2016 Jul;39(7):1241-9. doi: 10.2337/dc15-1643. Epub 2015 Dec 17. Diabetes Care. 2016. PMID: 26681715 Clinical Trial.
345 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback